Zhifei Cao Selected Research

cadherin 5

1/2019	Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation.
1/2018	Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
1/2017	MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression.
5/2014	Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms.
8/2013	Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells.
9/2012	Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhifei Cao Research Topics

Disease

26	Neoplasms (Cancer) 08/2021 - 02/2012
6	Neoplasm Metastasis (Metastasis) 07/2021 - 03/2012
4	Carcinogenesis 01/2019 - 04/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 09/2015
3	Melanoma (Melanoma, Malignant) 01/2019 - 09/2012
3	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 04/2013
2	Lymphoma (Lymphomas) 10/2015 - 12/2012
2	Osteosarcoma (Osteogenic Sarcoma) 05/2014 - 12/2012
1	Colorectal Neoplasms (Colorectal Cancer) 07/2021
1	Lymphatic Metastasis 07/2021
1	Diabetes Mellitus 01/2021
1	Adenocarcinoma 01/2021
1	Aneuploidy (Aneuploid) 01/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020
1	Genomic Instability 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hypercholesterolemia 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017
1	Leukemia 02/2017
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Inflammation (Inflammations) 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2012
1	Sarcoma (Soft Tissue Sarcoma) 02/2012

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2020 - 02/2012
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2012
6	triptonideIBA 01/2020 - 02/2017
6	cadherin 5IBA 01/2019 - 09/2012
3	Messenger RNA (mRNA)IBA 08/2021 - 01/2017
3	lycorineIBA 01/2019 - 09/2012
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2015 - 02/2012
3	Monoclonal AntibodiesIBA 06/2012 - 02/2012
2	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2017
2	Atorvastatin (Lipitor)FDA Link 01/2019 - 01/2016
2	matrigelIBA 01/2018 - 06/2012
2	dehydroeffusolIBA 03/2016 - 09/2015
2	Endoplasmic Reticulum Chaperone BiPIBA 03/2016 - 10/2015
2	Oxygen (Dioxygen)IBA 09/2015 - 03/2012
1	RNA (Ribonucleic Acid)IBA 08/2021
1	CEACAM1 ProteinIBA 08/2021
1	Member 6b Tumor Necrosis Factor ReceptorsIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Long Noncoding RNAIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	UbiquitinIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 01/2020
1	Notch1 ReceptorIBA 01/2020
1	SterolsIBA 01/2020
1	Liver X ReceptorsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	CateninsIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	AlkaloidsIBA 01/2019
1	isoquinolineIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	LuciferasesIBA 01/2018
1	Chemokine CXCL2IBA 01/2018
1	ChemokinesIBA 01/2018
1	LigandsIBA 01/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2017
1	DiterpenesIBA 02/2017
1	3' Untranslated Regions (3' UTR)IBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 03/2016
1	phenanthreneIBA 03/2016
1	Activating Transcription Factor 4IBA 03/2016
1	oroxin AIBA 03/2016
1	ThrombomodulinIBA 01/2016
1	CholesterolIBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	oroxin BIBA 10/2015
1	Peptide Hydrolases (Proteases)FDA Link 09/2015
1	Cyclin D1IBA 05/2014
1	coptisineIBA 05/2014
1	IntegrinsIBA 05/2014
1	jatrorrhizineIBA 08/2013
1	columbamineIBA 12/2012
1	scutellarinIBA 12/2012
1	FilaminsIBA 06/2012
1	Peptides (Polypeptides)IBA 03/2012
1	Bevacizumab (Avastin)FDA Link 03/2012

Therapy/Procedure

19	Therapeutics 07/2021 - 03/2012
1	Immunotherapy 12/2012
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2012